VCM
GMAB icon

Versant Capital Management’s Genmab GMAB Stock Holding History

Versant Capital Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$322K Sell
11,712
-1,908
-14% -$50.7K 0.03% 439
2026
Q1 		$365K Buy
13,620
+2,965
+28% +$88.9K 0.04% 361
2025
Q4 		$328K Sell
10,655
-213
-2% -$6.64K 0.04% 331
2025
Q3 		$333K Buy
10,868
+301
+3% +$7.33K 0.05% 328
2025
Q2 		$218K Buy
10,567
+1,843
+21% +$37.8K 0.03% 413
2025
Q1 		$171K Buy
8,724
+8,002
+1,108% +$168K 0.03% 468
2024
Q4 		$15.1K Buy
+722
New +$15.9K ﹤0.01% 1179
2023
Q4 		– Sell
-88
Closed -$3.1K – 1957
2023
Q3 		$3.1K Hold
88
– – ﹤0.01% 1152
2023
Q2 		$3.35K Hold
88
– – ﹤0.01% 1178
2023
Q1 		$3.32K Buy
+88
New +$3.38K ﹤0.01% 1096

Other funds holding GMAB

PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
LWAM
Legacy Wealth Asset Management Woodbury, Minnesota $456M AUM 35.19% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
SOAM
SBI Okasan Asset Management Tokyo, Japan $3.04B AUM
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
GCM
Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Versant Capital Management's GMAB Position: Q2 2026 in Review

Versant Capital Management reduced its Genmab (GMAB) stake by 14% in Q2 2026, selling an estimated $50.7K and leaving 11,712 shares worth $322K. The position accounts for 0.03% of the portfolio, ranked #439.

Versant Capital Management first reported a position in GMAB in Q1 2023 and has held it in 10 quarters since. The position peaked at $365K in Q1 2026. 41 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Versant Capital Management held 11,712 shares of Genmab worth $322K as of Q2 2026.
  • Versant Capital Management sold 1,908 Genmab shares in Q2 2026, an estimated $50.7K.
  • Genmab made up 0.03% of Versant Capital Management's portfolio in Q2 2026, its #439 holding.
  • Versant Capital Management first reported a position in Genmab in Q1 2023 and has held it in 10 quarters since.
  • Versant Capital Management's Genmab position peaked at $365K in Q1 2026.
  • 41 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.